Nebulized medication therapy is the standard of care for bronchodilation in respiratory patients. However, the use of salbutamol nebules generates aerosol, which increases the risk of droplet contamination that can remain in the air and spread virus particles. The use of salbutamol pressurized metered dose inhalers (pMDIs) reduces the risk of aerosol-generating particles [1]. Therefore, pMDIs (Fig. 1) are preferred when trying to reduce viral transmission.